HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous antihypertensive therapy throughout the initial 24 hours of intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study.

AbstractBACKGROUND AND PURPOSE:
A short duration (<24 hours) of antihypertensive therapy (AHT) after acute intracerebral hemorrhage (ICH) may be sufficient because active bleeding generally ceases within several hours. We aimed to determine the association between sequential systolic blood pressure (SBP) levels during AHT and outcomes in ICH patients.
METHODS:
In 211 hyperacute ICH patients who underwent AHT based on predefined protocol, the mean of hourly SBP (mSBP) measurements was calculated over 1 to 8 hours (first mSBP), 9 to 16 hours (second mSBP), and 17 to 24 hours (third mSBP) after the initiation of AHT. Outcomes included neurological deterioration (72-hour Glasgow Coma Scale decrease ≥2 or National Instititutes of Health Stroke Scale increase ≥4), hematoma expansion (>33%), and unfavorable outcome (3-month modified Rankin Scale score 4-6).
RESULTS:
The median first, second, and third mSBPs were 132, 131, and 137 mm Hg, respectively. A higher first mSBP (odds ratio [OR], 2.41; 95% confidence interval [CI], 1.34-4.69 per 10 mm Hg) or second mSBP (OR, 2.08; 95% CI, 1.20-3.80) was independently associated with neurological deterioration, and a higher second mSBP (OR, 1.40; 95% CI, 1.02-2.00) or third mSBP (OR, 1.45; 95% CI, 1.05-2.05) was associated with unfavorable outcome. None of the mSBPs was associated with hematoma expansion.
CONCLUSIONS:
The continuation of AHT throughout the initial 24 hours after ICH may improve outcomes.
AuthorsJunpei Kobayashi, Masatoshi Koga, Eijirou Tanaka, Yasushi Okada, Kazumi Kimura, Hiroshi Yamagami, Satoshi Okuda, Yasuhiro Hasegawa, Yoshiaki Shiokawa, Eisuke Furui, Jyoji Nakagawara, Kazuomi Kario, Takuya Okata, Shoji Arihiro, Shoichiro Sato, Kazuyuki Nagatsuka, Kazuo Minematsu, Kazunori Toyoda, SAMURAI Study Investigators
JournalStroke (Stroke) Vol. 45 Issue 3 Pg. 868-70 (Mar 2014) ISSN: 1524-4628 [Electronic] United States
PMID24425118 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antihypertensive Agents
Topics
  • Aged
  • Antihypertensive Agents (therapeutic use)
  • Blood Pressure (drug effects)
  • Cerebral Hemorrhage (drug therapy)
  • Confidence Intervals
  • Disease Progression
  • Female
  • Glasgow Coma Scale
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Nervous System Diseases (epidemiology, pathology)
  • Risk Factors
  • Stroke (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: